Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
March 11th, 2021
Radiation dosimetry provides a technique for enhancing the accuracy of preclinical experiments and ensuring that the radiation doses delivered are closely related to clinical parameters. This protocol describes steps to be taken at each phase during preclinical radiation experiments to ensure proper experimental design.
This protocol is a novel combination of several radio biological and radiation dosimeteric methodologies to ensure accurate, reproducible, preclinical radiation therapy experiments. These methods link experimental conditions to national dose standards and allow for the accurate measurements of doses that match radiation treatment doses. Focusing on the design of reproducible radiotherapy experiments, this protocol provides researchers with the tools and methods necessary to perform studies with a high translational relevance.
Dosimetric calibration protocols can be challenging for novices, especially for those without the background in medical physics. We suggest consulting a radiation therapy physicist when first attempting these experiments. The techniques in this protocol are common to both radiation physicists and biomedical researchers.
However, some of these are not typically utilized in combination. To determine the appropriate dose output, set the irradiator to deliver radiation at a 220 peak kilovoltage and 13 milliamps with a 17 by 17 centimeter open field positioned 35 centimeters from the source. Filter the beam with a 0.15 millimeter copper filter with a broad focus and align the one centimeter slab, the two centimeter slab, the two centimeter slab with the ionization chamber and the one centimeter slab.
After setting up the phantom stack, insert the ionization chamber into the phantom and adjust the stacks such that the source to surface distance is 33 centimeters when appropriately leveled. Then confirm that these measurements are correctly placed within the ionization chamber at 35 centimeters from the isocenter. To create a radio chromic film calibration curve, prepare several additional pieces of film of the same size and orientation and place the film at a two centimeter depth in the solid water phantom stack.
To begin the irradiation, place one piece of film on top of four centimeters of solid water and place the remaining two centimeters of solid water above the films. After requiring post-exposure film scans, import the image files into ImageJ in a tiff file format and select Image, Color and select Split Channels. In the red image channel only, use the rectangle tool to draw a region of interest and press Ctrl+M to allow the mean values to be transcribed from the results window.
Once all of the pixel values have been obtained for the unexposed and exposed films, calculate the net optical density using the equation as indicated, then plot the net optical density against the dose at which the film was exposed and fit the plot with a quadratic curve. To determine the alpha/beta value for specific cancer cell lines via a clonogenic assay, count the resultant number of colonies in each treatment group to allow calculation of the survival fraction of each plate, then plot the natural log of the survival fraction against the corresponding dose delivered and fit the curve with a quadratic function. To determine the specific dose output for variable experimental designs, select a desired field size and distance from the source and use solid water phantoms to provide buildup and backscatter as needed, positioning the piece of film in the orientation that best portrays the experimental design.
The dose can then be determined from the net optical density of the film using the film calibration curve for the dose. To determine the appropriate beam position for a tumor bearing mouse treatment, after confirming a lack of response to pedal reflex, use an onboard portal camera and an aluminum filter to obtain a radiogram of the experimental mouse without collimation, then obtain a radiogram with collimation in place and overlay the radiograms in ImageJ to determine the beam positioning. Utilizing the calibration curve as demonstrated, two film samples can be generated that can be used to estimate the required experimental irradiation times.
Overlaying these images will reveal the exact positioning of the collimated radiation beam relative to the small animal being treated. Successful dose deposition can then be confirmed as illustrated by the positive gamma-H2AX staining observed within the treated hemisphere only in this representative analysis. Remaining consistent when moving from determining irradiator output to generating a film calibration curve and when determining dose for your ideal experimental design is critical.
Following these protocols enables researchers to study a wide variety of clinically applicable radiobiological questions in a preclinical setting. These questions may lead to a better understanding of patient outcomes. This protocol isn't a standalone new technique.
However, combining these methodologies will lead to direct clinical relevance and give insights into the outcomes for doses seen in the clinic.
Overview
This protocol enhances the accuracy of preclinical radiation therapy experiments by linking experimental conditions to national dose standards. Researchers are provided with methodologies to ensure proper experimental design, ultimately leading to more clinically relevant outcomes.
Key Study Components
Research Area
- Radiation dosimetry
- Preclinical experimentation
- Oncology
Background
- Radiation dosimetry techniques improve experimental accuracy.
- Challenges exist for novices without a medical physics background.
- Combining methodologies provides enhanced reproducibility.
Methods Used
- Calibration protocols for dosimetric measurements
- Solid water phantoms and ionization chambers for dose determination
- Usage of radiochromic film for dose calibration and dose output assessment
Main Results
- Methods linked to clinical radiation treatment doses.
- Successful estimation of irradiation times and dose delivery.
- Provided insights into preclinical radiobiological questions.
Conclusions
- This study showcases a method to enhance the design of radiation therapy experiments.
- Results are relevant for advancing understanding in cancer treatment outcomes.
Frequently Asked Questions
Executive Industry Relevance
Accurate radiation dosimetry is essential for reproducible preclinical radiation therapy studies, enabling direct translation of dosing regimens to clinical contexts. This protocol links experimental irradiation parameters to national standards, reducing variability in effective dose delivery across in vitro and in vivo models. By establishing dose-response relationships through clonogenic assays and film-based calibration, researchers can de-risk translational predictions in oncology drug-radiation combination studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables mechanistic interrogation of DNA damage response pathways via gamma-H2AX staining as a functional readout of radiation-induced double-strand breaks.
- Operational Value: Provides quantitative survival fraction data from clonogenic assays to define intrinsic radiosensitivity of cancer cell lines for target prioritization.
- Predictive Value: Supports estimation of alpha/beta parameters from linear-quadratic modeling to inform fractionation schedules with equivalent biologic effective doses.
Screening & Assay Development
- Assay Readiness: Establishes standardized radiochromic film calibration curves for reproducible dose measurement across variable field sizes and depths in solid water phantoms.
- Quantitative Output: Delivers net optical density-to-dose conversion via quadratic curve fitting, enabling precise dose deposition verification in small-animal experiments.
- Platform Reuse: Facilitates cross-experiment consistency by reusing ionization chamber and film-based dosimetry setups for different irradiator configurations.
Translational & Preclinical Research
- Disease Relevance: Allows alignment of preclinical radiation schedules with clinically equivalent biologic effective doses using LQ model-derived parameters.
- Translational Continuity: Bridges in vitro radiosensitivity screening to in vivo dose deposition validation in tumor-bearing models through consistent dosimetric traceability.
- Risk-Adjusted Advancement: Reduces confounding in combination therapy studies by ensuring delivered radiation doses match intended effective doses across experimental groups.
Pipeline & Workflow Integration
This method integrates into the oncology discovery continuum from target validation through lead optimization, particularly for radiation-modulating agents where dose accuracy impacts pharmacodynamic readouts.
- Discovery Biology: Supports hypothesis testing of DNA repair mechanisms by enabling precise radiation dosing to generate quantifiable gamma-H2AX foci in treated tissues.
- Screening: Ensures assay reproducibility through solid water phantom-based buildup and backscatter correction for consistent dose delivery across multi-well plate formats.
- Analytics: Provides survival fraction and natural log-transformed dose-response datasets for quadratic curve fitting to extract alpha and beta parameters.
- Translational Research: Connects clonogenic-derived alpha/beta ratios to in vivo fractionation schemes via biologic effective dose principles for equivalent tumor control probability.
- Enterprise Reuse: Establishes a reusable dosimetry framework applicable across irradiator models and experimental designs, reducing setup variability in multi-site preclinical studies.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of radiation-induced biomarkers through validated dose deposition in specific anatomical regions.
- Operational Value: Standardization of radiation output verification via ionization chamber and film-based cross-calibration against national dosimetry standards.
- Strategic Value: Improved go/no-go decisions for radiation-combination therapies by eliminating dose-delivery variance as a confounding factor.
- Portfolio Impact: Enables risk-adjusted prioritization of drug candidates based on reproducible radiosensitivity modulation in clinically relevant dosing schemas.
Implementation Considerations
- Requires expertise in radiation safety and basic dosimetry principles for proper phantom setup and irradiator alignment.
- Dependent on instrumentation including electrometer, ionization chamber, solid water phantoms, radiochromic film, and image analysis software (e.g., ImageJ).
- Necessitates cross-team standardization between radiation physicists and biologists to ensure consistent interpretation of dose metrics.
- Involves adaptation considerations for varying field sizes, depths, and source-to-surface distances when modeling different experimental designs.
- Practical limitations include film fading effects requiring timely post-exposure scanning and the need for energy-specific correction factors when deviating from calibrated beam qualities.
Biopharma FAQs
Chapters in this video
0:05
Introduction
1:14
Dose Output Determination
2:12
Radiochromic Film Calibration Curve Creating
3:26
Alpha/beta and Specific Dose Output Value Determination
4:22
Beam Positioning for Mouse Tumor Treatment
4:52
Results: Representative Irradiator Commissioning and Dosimetry
5:28
Conclusion
